Patents by Inventor LAURENT MONASSIER

LAURENT MONASSIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of valvular heart disease comprising administering a composition comprising sarpogrelate
    Patent number: 11116741
    Abstract: The present invention relates to the use of a serotoninergic receptor antagonist, such as sarpogrelate or compositions thereof, for the treatment and/or prevention of heart damages in mammals.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: September 14, 2021
    Assignee: CEVA SANTE ANIMALE
    Inventors: Estelle Ayme-Dietrich, Jérôme Guyonnet, Roland Lawson, Luc Maroteaux, Laurent Monassier
  • METHOD FOR THE TREATMENT OF HEART DISEASE IN MAMMALS
    Publication number: 20200297685
    Abstract: The present invention relates to the use of a serotoninergic receptor antagonist for the treatment and/or prevention of heart damages in mammals.
    Type: Application
    Filed: April 11, 2018
    Publication date: September 24, 2020
    Inventors: ESTELLE AYME-DIETRICH, JÉRÔME GUYONNET, ROLAND LAWSON, LUC MAROTEAUX, LAURENT MONASSIER